Cyanobacterial lipopolysaccharides and human health - A review

Environmental Health: A Global Access Science Source

Volumn 5, Issue , 2006, Pages

  Stewart, Ian ^a,b   Schluter, Philip J ^c   Shaw, Glen R ^a,b,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Department of Applied Chemistry   (Australia)

^c AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^d GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN;

ALLERGIC REACTION; CYANOBACTERIUM; DIARRHEA; GASTROINTESTINAL INFECTION; LITERATURE; PROTEIN STRUCTURE; RASH; RESPIRATORY TRACT ALLERGY; REVIEW; VOMITING;

ANIMALS; BACTERIAL INFECTIONS; BACTERIAL TOXINS; CYANOBACTERIA; ENVIRONMENTAL EXPOSURE; GRAM-NEGATIVE BACTERIA; HUMANS; LIPOPOLYSACCHARIDES; MALE; MARINE TOXINS; MICROCYSTINS; MIDDLE AGED; WATER MICROBIOLOGY;

BACTERIA (MICROORGANISMS); CYANOBACTERIA; ENTEROBACTERIACEAE; NEGIBACTERIA; PHOTOBACTERIA;

EID: 33745835454     PISSN: 1476069X     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-5-7     Document Type: Review

References (286)

1. Moe CL: Waterborne transmission of infectious agents. In Manual of environmental microbiology Edited by: Hurst CJ, Knudsen GR, McInerney MJ, Stetzenbach LD, Walter MV. Washington, DC: American Society for Microbiology; 1997:136-152.
2. Sivonen K, Jones G: Cyanobacterial toxins. In Toxic cyanobacteria in water - a guide to their public health consequences, monitoring and management Edited by: Chorus I, Bartram J. London: E & FN Spon; 1999:41-111.
3. Wiegand C, Pflugmacher S: Ecotoxicological effects of selected cyanobacterial secondary metabolites a short review. Toxicol Appl Pharmacol 2005, 203:201-218.
4. Hitzfeld BC, Hoger SJ, Dietrich DR: Cyanobacterial toxins: removal during drinking water treatment, and human risk assessment. Environ Health Perspect 2000, 108(Suppl 1):113-122.
5. Mwaura F, Koyo AO, Zech B: Cyanobacterial blooms and the presence of cyanotoxins in small high altitude tropical headwater reservoirs in Kenya. J Water Health 2004, 2:49-57.
6. Burch MD: Cyanobacteria and water quality: new problems and challenges. In Seminar on drinking water quality: Technical and management issues for the 1990s Adelaide: Australian Water and Wastewater Association; 1993:18-24.
7. Carmichael WW, Falconer IR: Diseases related to freshwater blue-green algal toxins, and control measures. In Algal toxins in seafood and drinking water Edited by: Falconer IR. London: Academic Press; 1993:187-209.
8. Codd GA, Edwards C, Beattie KA, Lawton LA, Campbell DL, Bell SG: Toxins from cyanobacteria (blue-green algae) - The Pringsheim lecture. In Algae, environment and human affairs Edited by: Wiessner W, Schnepf E, Starr RC. Bristol: Biopress; 1995:1-17.
9. Bartram J, Carmichael WW, Chorus I, Jones G, Skulberg OM: Introduction. In Toxic cyanobacteria in water - a guide to their public health consequences, monitoring and management Edited by: Chorus I, Bartram J. London: E & FN Spon; 1999:1-14.
10. Codd GA, Bell SG, Kaya K, Ward CJ, Beattie KA, Metcalf JS: Cyanobacterial toxins, exposure routes and human health. Eur J Phycol 1999, 34:405-415.
11. Kuiper-Goodman T, Falconer I, Fitzgerald J: Human health aspects. In Toxic cyanobacteria in water - a guide to their public health consequences, monitoring and management Edited by: Chorus I, Bartram J. London: E & FN Spon; 1999:113-153.
12. Steffensen D, Burch M, Nicholson B, Drikas M, Baker P: Management of toxic blue-green algae (cyanobacteria) in Australia. Environ Toxicol 1999, 14:183-195.
13. Codd GA: Cyanobacterial toxins, the perception of water quality, and the prioritisation of eutrophication control. Ecol Eng 2000, 16:51-60.
14. Carmichael WW: Assessment of blue-green algal toxins in raw and finished drinking water. Denver: AWWA Research Foundation and American Water Works Association; 2001.
15. Chorus I, Fastner J: Recreational exposure to cyanotoxins. In Cyanotoxins - occurrence, causes, consequences Edited by: Chorus I. Berlin: Springer-Verlag; 2001:190-199.
16. Carmichael WW: Freshwater blue-green algae (cyanobacteria) toxins - a review. In The water environment - Algal toxins and health Edited by: Carmichael WW. New York: Plenum; 1981:1-13.
17. Codd GA, Poon GK: Cyanobacterial toxins. In Biochemistry of the algae and cyanobacteria Edited by: Rogers LJ, Gallon JR. Oxford: Clarendon Press; 1988:283-296.
18. de Figueiredo DR, Azeiteiro UM, Esteves SM, Gonçalves FJM, Pereira MJ: Microcystin-producing blooms - a serious global public health issue. Ecotoxicol Environ Saf 2004, 59:151-163.
19. NSW algal information:What problems are caused by blue-green algae? [http://www.dlwc.nsw.gov.au/care/water/bga/problems.html]
20. Shaw G, Garnett C, Moore MR, Florian P: The predicted impact of climate change on toxic algal (cyanobacterial) blooms and toxin production in Queensland. Environ Health 2001, 1:76-88.
21. Hindman SH, Favero MS, Carson LA, Petersen NJ, Schonberger LB, Solano JT: Pyrogenic reactions during haemodialysis caused by extramural endotoxin. Lancet 1975, 2:732-734.
22. Stanier RY, Cohen-Bazire G: Phototrophic prokaryotes: the cyanobacteria. Annu Rev Microbiol 1977, 31:225-274.
23. Codd GA: Blue-green algal toxins: water-borne hazards to health. In Water and public health Edited by: Golding AMB, Noah N, Stanwell-Smith R. London: Smith-Gordon; 1994:271-278.
24. Holt JG, Krieg NR, Sneath PHA, Staley JT, Williams ST: Bergey's manual of determinative bacteriology. 9th edition. Baltimore: Williams & Wilkins; 1994.
25. Hunter PR: Waterborne disease. Epidemiology and ecology. Chichester: John Wiley & Sons; 1997.
26. Duy TN, Lam PKS, Shaw GR, Connell DW: Toxicology and risk assessment of freshwater cyanobacterial (blue-green algal) toxins in water. Rev Environ Contam Toxicol 2000, 163:113-185.
27. Weckesser J, Drews G, Mayer H: Lipopolysaccharides of photosynthetic prokaryotes. Annu Rev Microbiol 1979, 33:215-239.
28. Weckesser J, Katz A, Drews G, Mayer H, Fromme I: Lipopolysaccharide containing L-acofriose in the filamentous blue-green alga Anabaena variabilis. J Bacteriol 1974, 120:672-678.
29. Drews G: Fine structure and chemical composition of the cell envelopes. In The biology of blue-green algae Edited by: Carr NG, Whitton BA. Oxford: Blackwell Scientific; 1973:99-116.
30. Golecki JR: Analysis of the structure and development of bacterial membranes (outer, cytoplasmic and intracytoplasmic membranes). Methods Microbiol 1988, 20:61-77.
31. Lugtenberg B, Van Alphen L: Molecular architecture and functioning of the outer membrane of Escherichia coli and other gram-negative bacteria. Biochim Biophys Acta 1983, 737:51-115.
32. Hobot JA: Bacterial ultrastructure. In Molecular medical microbiology Volume 1. Edited by: Sussman M. London: Academic Press; 2002:7-32.
33. Jürgens UJ, Weckesser J: The fine structure and chemical composition of the cell wall and sheath layers of cyanobacteria. Ann Inst Pasteur Microbiol 1985, 136A:41-44.
34. Margulis L, Schwartz KV: Five kingdoms: an illustrated guide to the phyla of life on earth. 3rd edition. New York: WH Freeman & Co.; 1998.
35. Hughes EO, Gorham PR, Zehnder A: Toxicity of a unialgal culture of Microcystis aeruginosa. Can J Microbiol 1958, 4:225-236.
36. Gorham PR: Toxic waterblooms of blue-green algae. Can Vet J 1960, 1:235-245.
37. McBarron EJ, May V: Poisoning of sheep in New South Wales by the blue-green alga Anacystis cyanea (Kuetz.) Dr. and Dail. Aust Vet J 1966, 42:449-453.
38. Murthy JR, Capindale JB: A new isolation and structure for the endotoxin from Microcystis aeruginosa NRC-1. Can J Biochem 1970, 48:508-510.
39. Heaney SI: The toxicity of Microcystis aeruginosa Kutz from some English reservoirs. Water Treat Exam 1971, 20:235-244.
40. Rabin P, Darbre A: An improved extraction procedure for the endotoxin from Microcystis aeruginosa NRC-1. Biochem Soc Trans 1975, 3:428-430.
41. Elleman TC, Falconer IR, Jackson AR, Runnegar MT: Isolation, characterization and pathology of the toxin from a Microcystis aeruginosa (= Anacystis cyanea) bloom. Aust J Biol Sci 1978, 31:209-218.
42. Kay RO: Microalgae as food and supplement. Crit Rev Food Sci Nutr 1991, 30:555-573.
43. Gentile JH, Maloney TE: Toxicity and environmental requirements of a strain of Aphanizomenon flos-aquae (L.) Ralfs. Can J Microbiol 1969, 15:165-173.
44. Frank AA, Blythe LL, Spencer PS: Aspects of veterinary neurotoxicology. In Experimental and clinical neurotoxicology Edited by: Spencer PS, Schaumburg HH. New York: Oxford University Press; 2000:83-105.
45. Zurawell RW, Chen H, Burke JM, Prepas EE: Hepatotoxic cyanobacteria: a review of the biological importance of microcystins in freshwater environments. J Toxicol Environ Health B Crit Rev 2005, 8:1-37.
46. Ellis S: Brevetoxins: chemistry and pharmacology of 'red tide' toxins from Ptychodiscus brevis (formerly Gymnodinium breve). Toxicon 1985, 23:469-472.
47. Martich GD, Boujoukos AJ, Suffredini AF: Response of man to endotoxin. Immunobiology 1993, 187:403-416.
48. Schletter J, Heine H, Ulmer AJ, Rietschel ET: Molecular mechanisms of endotoxin activity. Arch Microbiol 1995, 164:383-389.
49. Henderson B, Poole S, Wilson M: Bacteria-cytokine interactions in health and disease. London: Portland Press; 1998.
50. Morrison DC, Raziuddin S: Lipopolysaccharides and endotoxin. In Immunopharmacology Edited by: Sirois P, Rola-Pleszczynski M. Amsterdam: Elsevier Biomedical Press; 1982:169-199.
51. Rietschel ET, Brade H, Holst O, Brade L, Muller-Loennies S, Mamat U, Zahringer U, Beckmann F, Seydel U, Brandenburg K, Ulmer AJ, Mattern T, Heine H, Schletter J, Loppnow H, Schonbeck U, Flad HD, Hauschildt S, Schade UF, Di Padova F, Kusumoto S, Schumann RR: Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996, 216:39-81.
52. Lynn WA, Golenbock DT: Lipopolysaccharide antagonists. Immunol Today 1992, 13:271-276.
53. Elsbach P, Weiss J: The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 1993, 187:417-429.
54. Seydel U, Labischinski H, Kastowsky M, Brandenburg K: Phase behavior, supramolecular structure, and molecular conformation of lipopolysaccharide. Immunobiology 1993, 187:191-211.
55. Olson NC, Hellyer PW, Dodam JR: Mediators and vascular effects in response to endotoxin. Br Vet J 1995, 151:489-522.
56. Holst O, Ulmer AJ, Brade H, Flad HD, Rietschel ET: Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol Med Microbiol 1996, 16:83-104.
57. Matsuura M, Kawahara K, Ezaki T, Nakano M: Biological activities of lipopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. FEMS Microbiol Lett 1996, 137:79-83.
58. Codd GA, Brooks WP, Lawton LA, Beattie KA: Cyanobacterial toxins in European waters: occurrence, properties, problems and requirements. In Watershed 89 The future for water quality in Europe Volume 2. Edited by: Wheeler D, Richardson MJ, Bridges J. Oxford: Pergamon Press; 1989:211-220.
59. Environmental health assessment guidelines: Cyanobacteria in recreational and drinking waters [http://www.health.qld.gov.au/phs/Documents/ehu/11870.pdf]
60. Svrcek C, Smith DW: Cyanobacteria toxins and the current state of knowledge on water treatment options: a review. J Environ Eng Sci 2004, 3:155-185.
61. Burrell R: Human responses to bacterial endotoxin. Circ Shock 1994, 43:137-153.
62. Hewett JA, Roth RA: Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev 1993, 45:382-411.
63. Alexander C, Rietschel ET: Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001, 7:167-202.
64. Heumann D, Glauser MP, Calandra T: The generation of inflammatory responses. In Molecular medical microbiology Volume 1. Edited by: Sussman M. London: Academic Press; 2002:687-727.
65. Hamblin AS: Regulation of the immune system by pharmacological and biological mediators. In Principles and practice of immunotoxicology Edited by: Miller K, Turk JL, Nicklin S. Oxford: Blackwell Scientific Publications; 1992:24-49.
66. Brandtzaeg P: Significance and pathogenesis of septic shock. Curr Top Microbiol Immunol 1996, 216:15-37.
67. Wright SD: Innate recognition of microbial lipids. In Inflammation: Basic principles and clinical correlates 3rd edition. Edited by: Gallin JI, Snyderman R. Philadelphia: Lippincott Williams & Wilkins; 1999:525-535.
68. Tobias PS, Tapping RI, Gegner JA: Endotoxin interactions with lipopolysaccharide-responsive cells. Clin Infect Dis 1999, 28:476-481.
69. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
70. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
71. Schnaitman CA: The genetics and biosynthesis of lipopolysaccharides. In Molecular medical microbiology Volume 1. Edited by: Sussman M. London: Academic Press; 2002:93-136.
72. Morrison DC: Bacterial endotoxins and pathogenesis. Rev Infect Dis 1983, 5(Suppl 4):S733-747.
73. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ 3rd, Zentella A, Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 1986, 234:470-474.
74. Galanos C, Freudenberg MA: Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 1993, 187:346-356.
75. Müller-Loennies S, Zähringer U, Seydel U, Kusumoto S, Ulmer AJ, Rietschel ET: What we know and don't know about the chemical and physical structure of lipopolysaccharide in relation to biological activity. In Endotoxin and sepsis Molecular mechanisms of pathogenesis, host resistance, and therapy Edited by: Levin J, Pollack M, Yokochi T, Nakano M. New York: Wiley-Liss; 1998:51-72.
76. Qureshi ST, Gros P, Malo D: The Lps locus: genetic regulation of host responses to bacterial lipopolysaccharide. Inflamm Res 1999, 48:613-620.
77. Sing A, Merlin T, Knopf HP, Nielsen PJ, Loppnow H, Galanos C, Freudenberg MA: Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component. Infect Immun 2000, 68:1600-1607.
78. Rietschel ET, Brade L, Lindner B, Zahringer U: Biochemistry of lipopolysaccharides. In Bacterial endotoxic lipopolysaccharides Volume 1. Edited by: Morrison DC, Ryan JL. Boca Raton: CRC Press; 1992:3-41.
79. Ulevitch RJ, Tobias PS: Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999, 11:19-22.
80. Lüderitz O, Galanos C, Lehmann V, Nurminen M, Rietschel ET, Rosenfelder G, Simon M, Westphal O: Lipid A: Chemical structure and biological activity. In Bacterial lipopolysaccharides The chemistry, biology, and clinical significance of endotoxins Edited by: Kass EH, Wolff SM. Chicago: University of Chicago Press; 1973:9-21.
81. Galanos C, Lüderitz O, Rietschel ET, Westphal O, Brade H, Brade L, Freudenberg M, Schade U, Imoto M, Yoshimura H, Kusumoto S, Shiba T: Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem 1985, 148:1-5.
82. Erwin AL, Mandrell RE, Munford RS: Enzymatically deacylated Neisseria lipopolysaccharide (LPS) inhibits murine splenocyte mitogenesis induced by LPS. Infect Immun 1991, 59:1881-1887.
83. Wiese A, Brandenburg K, Ulmer AJ, Seydel U, Müller-Loennies S: The dual role of lipopolysaccharide as effector and target molecule. Biol Chem 1999, 380:767-784.
84. Takayama K, Qureshi N: Chemical structure of lipid A. In Bacterial endotoxic lipopolysaccharides Volume 1. Edited by: Morrison DC, Ryan JL. Boca Raton: CRC Press; 1992:43-65.
85. Jagielo PJ, Quinn TJ, Qureshi N, Schwartz DA: Grain dust-induced lung inflammation is reduced by Rhodobacter sphaeroides diphosphoryl lipid A. Am J Physiol 1998, 274:L26-31.
86. Masoud H, Lindner B, Weckesser J, Mayer H: The structure of the lipid A component of Rhodocyclus gelatinosus Dr2 lipopolysaccharide. System Appl Microbiol 1990, 13:227-233.
87. Lindberg AA, Weintraub A, Zähringer U, Rietschel ET: Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. Rev Infect Dis 1990, 12:S133-141.
88. Takada H, Kotani S: Structure-function relationships of lipid A. In Bacterial endotoxic lipopolysaccharides Volume 1. Edited by: Morrison DC, Ryan JL. Boca Raton: CRC Press; 1992:107-134.
89. Frieling JTM, Mulder JA, Hendriks T, Curfs JHAJ, van der Linden CJ, Sauerwein RW: Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment. Antimicrob Agents Chemother 1997, 41:1439-1443.
90. Wilson M, Seymour R, Henderson B: Bacterial perturbation of cytokine networks. Infect Immun 1998, 66:2401-2409.
91. Weintraub A, Zahringer U, Wollenweber HW, Seydel U, Rietschel ET: Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem 1989, 183:425-431.
92. Griffiss JM, Schneider H, Mandrell RE, Yamasaki R, Jarvis GA, Kim JJ, Gibson BW, Hamadeh R, Apicella MA: Lipooligosaccharides: the principal glycolipids of the neisserial outer membrane. Rev Infect Dis 1988, 10(Suppl 2):S287-295.
93. Preston A, Mandrell RE, Gibson BW, Apicella MA: The lipooligosaccharides of pathogenic gram-negative bacteria. Crit Rev Microbiol 1996, 22:139-180.
94. Raetz CRH: Biosynthesis of lipid A. In Bacterial endotoxic lipopolysaccharides Volume 1. Edited by: Morrison DC, Ryan JL. Boca Raton: CRC Press; 1992:67-80.
95. Munford RS, Hall CL: Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 1986, 234:203-205.
96. Riedo FX, Munford RS, Campbell WB, Reisch JS, Chien KR, Gerard RD: Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor-alpha. J Immunol 1990, 144:3506-3512.
97. Netea MG, van Deuren M, Kullberg BJ, Cavaillon JM, Van der Meer JW: Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends Immunol 2002, 23:135-139.
98. Seydel U, Brandenburg K: Supramolecular structure of lipopolysaccharides and lipid A. In Bacterial endotoxic lipopolysaccharides Volume 1. Edited by: Morrison DC, Ryan JL. Boca Raton: CRC Press; 1992:225-250.
99. Schromm AB, Brandenburg K, Loppnow H, Moran AP, Koch MH, Rietschel ET, Seydel U: Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem 2000, 267:2008-2013.
100. Seydel U, Schromm AB, Blunck R, Brandenburg K: Chemical structure, molecular conformation, and bioactivity of endotoxins. Chem Immunol 2000, 74:5-24.
101. Schromm AB, Brandenburg K, Loppnow H, Zahringer U, Rietschel ET, Carroll SF, Koch MH, Kusumoto S, Seydel U: The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J Immunol 1998, 161:5464-5471.
102. Seydel U, Scheel O, Muller M, Brandenburg K, Blunck R: A K+ channel is involved in LPS signaling. J Endotoxin Res 2001, 7:243-247.
103. Brandenburg K, Mayer H, Koch MH, Weckesser J, Rietschel ET, Seydel U: Influence of the supramolecular structure of free lipid A on its biological activity. Eur J Biochem 1993, 218:555-563.
104. Seydel U, Oikawa M, Fukase K, Kusumoto S, Brandenburg K: Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur J Biochem 2000, 267:3032-3039.
105. Ulmer AJ, Feist W, Heine H, Kirikae T, Kirikae F, Kusumoto S, Kusama T, Brade H, Schade U, Rietschel ET, Flad HD: Modulation of endotoxin-induced monokine release in human monocytes by lipid A partial structures that inhibit binding of 125I-lipopolysaccharide. Infect Immun 1992, 60:5145-5152.
106. Moran AP: Biological and serological characterization of Campylobacter jejuni lipopolysaccharides with deviating core and lipid A structures. FEMS Immunol Med Microbiol 1995, 11:121-130.
107. Rank P: A possible cause of arteriosclerosis. Med Hypotheses 1985, 17:107-131.
108. Rank P: Water and arteriosclerosis. Med Hypotheses 1987, 24:87-94.
109. Rank P: Arteriosclerosis in East Asians. Med Hypotheses 1987, 24:121-129.
110. Ahluwalia KB, Maheshwari N, Deka RC: Rhinosporidiosis: a study that resolves etiologic controversies. Am J Rhinol 1997, 11:479-483.
111. Ahluwalia KB: Culture of the organism that causes rhinosporidiosis. J Laryngol Otol 1999, 113:523-528.
112. Ahluwalia KB: Causative agent of rhinosporidiosis. J Clin Microbiol 2001, 39:413-415.
113. Annadotter H, Cronberg G, Lawton L, Hansson HB, Göthe U, Skulberg O: An extensive outbreak of gastroenteritis associated with the toxic cyanobacterium Planktothrix agardhii (Oscillatoriales, Cyanophyceae) in Scania, south Sweden. In Cyanotoxins - occurrence, causes, consequences Edited by: Chorus I. Berlin: Springer-Verlag; 2001:200-208.
114. Giesecke J: Modern infectious disease epidemiology. 2nd edition. London: Arnold; 2002.
115. Andrews PL, Hawthorn J: The neurophysiology of vomiting. Baillieres Clin Gastroenterol 1988, 2:141-168.
116. Grélot L, Miller AD: Vomiting - its ins and outs. News Physiol Sci 1994, 9:142-147.
117. Wood JD: Enteric nervous control of motility in the upper gastrointestinal tract in defensive states. Dig Dis Sci 1999, 44:44S-52S.
118. Borison HL: Area postrema: chemoreceptor circumventricular organ of the medulla oblongata. Prog Neurobiol 1989, 32:351-390.
119. Lang IM: Noxious stimulation of emesis. Dig Dis Sci 1999, 44:58S-63S.
120. Miller AD: Central mechanisms of vomiting. Dig Dis Sci 1999, 44:39S-43S.
121. Barnes JH: The physiology and pharmacology of emesis. Mol Aspects Med 1984, 7:397-508.
122. Girod V, Bouvier M, Grélot L: Characterization of lipopolysaccharide-induced emesis in conscious piglets: effects of cervical vagotomy, cyclooxygenase inhibitors and a 5-HT(3) receptor antagonist. Neuropharmacology 2000, 39:2329-2335.
123. Sugiyama H, Hayama T, Yagasaki O: Emetic action of bacterial endotoxin in the cat. Proc Soc Exp Biol Med 1966, 121:278-281.
124. Sugiyama H, Hayama T: Abdominal viscera as site of emetic action for staphylococcal enterotoxin in the monkey. J Infect Dis 1965, 115:330-336.
125. Sheth UK, Borison HL: Central pyrogenic action of Salmonella typhosa lipopolysaccharide injected into the lateral cerebral ventricle in cats. J Pharmacol Exp Ther 1960, 130:411-417.
126. Gilbert RP: Endotoxin shock in the primate. Proc Soc Exp Biol Med 1962, 111:328-331.
127. Martin WJ, Marcus S: Relation of pyrogenic and emetic properties of enterobacteriaceal endotoxin and of staphylococcal enterotoxin. J Bacteriol 1964, 87:1019-1026.
128. Sugiyama H, Bergdoll MS, Dack GM: Early development of a temporary resistance to the emetic action of staphylococcal enterotoxin. J Infect Dis 1962, 111:233-238.
129. Jett M, Ionin B, Das R, Neill R: The staphylococcal enterotoxins. In Molecular medical microbiology Volume 2. Edited by: Sussman M. London: Academic Press; 2002:1089-1116.
130. Bettelheim KA, Beutin L, Gleier K, Pearce JL, Luke RKJ, Zimmerman S: Serotypes of Escherichia coli isolated from healthy infants in Berlin, Germany and Melbourne, Australia. Comp Immunol Microbiol Infect Dis 2003, 26:55-63.
131. Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 2003, 361:512-519.
132. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA: Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci U S A 2000, 97:6043-6048.
133. Turner AK, Terry TD, Sack DA, Londono-Arcila P, Darsley MJ: Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans. Infect Immun 2001, 69:4969-4979.
134. Nataro JP: Diarrhoeagenic Escherichia coli. In Molecular medical microbiology Volume 2. Edited by: Sussman M. London: Academic Press; 2002:1463-1504.
135. Farthing MJ: Novel targets for the pharmacotherapy of diarrhoea: a view for the millennium. J Gastroenterol Hepatol 2000, 15(Suppl):G38-45.
136. Ahmed ZU, Sarker MR, Sack DA: Protection of adult rabbits and monkeys from lethal shigellosis by oral immunization with a thymine-requiring and temperature-sensitive mutant of Shigella flexneri Y. Vaccine 1990, 8:153-158.
137. Kollaritsch H, Cryz SJ Jr, Lang AB, Herzog C, Que JU, Wiedermann G: Local and systemic immune responses to combined vibrio cholerae CVD103-HgR and salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization. Vaccine 2000, 18:3031-3039.
138. Salerno-Goncalves R, Wyant TL, Pasetti MF, Fernandez-Vina M, Tacket CO, Levine MM, Sztein MB: Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA. J Immunol 2003, 170:2734-2741.
139. Altenhoefer A, Oswald S, Sonnenborn U, Enders C, Schulze J, Hacker J, Oelschlaeger TA: The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol Med Microbiol 2004, 40:223-229.
140. Stewart I, Webb PM, Schluter PJ, Fleming LE, Burns JW Jr, Gantar M, Backer LC, Shaw GR: Epidemiology of recreational exposure to freshwater cyanobacteria - an international prospective cohort study. BMC Public Health 2006, 6:93.
141. Oketani K, Inoue T, Murakami M: Effect of E3040 an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide. Eur J Pharmacol 3040, 427:159-166.
142. Yang JM, Han DW, Xie CM, Liang QC, Zhao YC, Ma XH: Endotoxins enhance hepatocarcinogenesis induced by oral intake of thioacetamide in rats. World J Gastroenterol 1998, 4:128-132.
143. Yoshino S, Sasatomi E, Mori Y, Sagai M: Oral administration of lipopolysaccharide exacerbates collagen-induced arthritis in mice. J Immunol 1999, 163:3417-3422.
144. Roth RA, Harkema JR, Pestka JP, Ganey PE: Is exposure to bacterial endotoxin a determinant of susceptibility to intoxication from xenobiotic agents? Toxicol Appl Pharmacol 1997, 147:300-311.
145. Yee SB, Kinser S, Hill DA, Barton CC, Hotchkiss JA, Harkema JR, Ganey PE, Roth RA: Synergistic hepatotoxicity from coexposure to bacterial endotoxin and the pyrrolizidine alkaloid monocrotaline. Toxicol Appl Pharmacol 2000, 166:173-185.
146. Ganey PE, Roth RA: Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents. Toxicology 2001, 169:195-208.
147. Jackson AR, McInnes A, Falconer IR, Runnegar MT: Clinical and pathological changes in sheep experimentally poisoned by the blue-green alga Microcystis aeruginosa. Vet Pathol 1984, 21:102-113.
148. Hawkins PR, Runnegar MT, Jackson AR, Falconer IR: Severe hepatotoxicity caused by the tropical cyanobacterium (blue-green alga) Cylindrospermopsis raciborskii (Woloszynska) Seenaya and Subba Raju isolated from a domestic water supply reservoir. Appl Environ Microbiol 1985, 50:1292-1295.
149. Falconer IR, Dornbusch M, Moran G, Yeung SK: Effect of the cyanobacterial (blue-green algal) toxins from Microcystis aeruginosa on isolated enterocytes from the chicken small intestine. Toxicon 1992, 30:790-793.
150. Falconer IR: Health problems from exposure to cyanobacteria and proposed safety guidelines for drinking and recreational water. In Detection methods for cyanobacterial toxins Edited by: Codd GA, Jefferies TM, Keevil CW, Potter E. Cambridge: The Royal Society of Chemistry; 1994:3-10.
151. Saker ML, Thomas AD, Norton JH: Cattle mortality attributed to the toxic cyanobacterium Cylindrospermopsis raciborskii in an outback region of north Queensland. Environ Toxicol 1999, 14:179-182.
152. Seawright AA, Nolan CC, Shaw GR, Chiswell RK, Norris RL, Moore MR, Smith MJ: The oral toxicity for mice of the tropical cyanobacterium Cylindrospermopsis raciborskii (Woloszynska). Environ Toxicol 1999, 14:135-142.
153. Fastner J, Heinze R, Humpage AR, Mischke U, Eaglesham GK, Chorus I: Cylindrospermopsin occurrence in two German lakes and preliminary assessment of toxicity and toxin production of Cylindrospermopsis raciborskii (cyanobacteria) isolates. Toxicon 2003, 42:313-321.
154. Rietschel RL, Fowler JF Jr: Fisher's Contact Dermatitis. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2001.
155. Arnold HL Jr, Odom RB, James WD: Andrews' diseases of the skin. Clinical dermatology. 8th edition. Philadelphia: W.B. Saunders; 1990.
156. Recreational exposure to freshwater cyanobacteria: epidemiology, dermal toxicity and biological activity of cyanobacterial lipopolysaccharides [http://eprint.uq.edu.au/archive/00001883/]
157. Jürgens UJ, Martin C, Weckesser J: Cell wall constituents of Microcystis sp. PCC 7806. FEMS Microbiol Lett 1989, 53:47-51.
158. Papageorgiou J, Linke TA, Kapralos C, Nicholson BC, Steffensen DA: Extraction of cyanobacterial endotoxin. Environ Toxicol 2004, 19:82-87.
159. Raziuddin S, Siegelman HW, Tornabene TG: Lipopolysaccharides of the cyanobacterium Microcystis aeruginosa. Eur J Biochem 1983, 137:333-336.
160. Scholtissek B, Jürgens UJ, Weckesser J: Purification and electrophoretic pattern of the lipopolysaccharide of Microcystis sp. PCC 7806. Arch Hydrobiol Suppl Algol Stud 1991, 64:361-368.
161. Katz A, Weckesser J, Drews G, Mayer H: Chemical and biological studies on the lipopolysaccharide (O-antigen) of Anacystis nidulans. Arch Microbiol 1977, 113:247-256.
162. Utili R, Abernathy CO, Zimmerman HJ: Endotoxin effects on the liver. Life Sci 1977, 20:553-568.
163. Musson RA, Morrison DC, Ulevitch RJ: Distribution of endotoxin (lipopolysaccharide) in the tissues of lipopolysaccharide-responsive and -unresponsive mice. Infect Immun 1978, 21:448-457.
164. Galanos C, Freudenberg MA, Katschinski T, Salomao R, Mossmann H, Kumazawa Y: Tumor necrosis factor and host response to endotoxin. In Bacterial endotoxic lipopolysaccharides Volume 2. Edited by: Ryan JL, Morrison DC. Boca Raton: CRC Press; 1992:75-104.
165. Kirkland TN, Ziegler EJ: An immunoprotective monoclonal antibody to lipopolysaccharide. J Immunol 1984, 132:2590-2592.
166. Ruggiero V, Piovesan P, Fabrizi C, Lauro GM, Campo S, Albertoni C, Nucera E, Carminati P, Ghirardi O: In vivo and In vitro cytokine modulatory activity of newly synthesised 2-aminotetraline derivatives. Shock 2004, 21:77-85.
167. Buttke TM, Ingram LO: Comparison of lipopolysaccharides from Agmenellum quadruplicatum to Escherichia coli and Salmonella typhimurium by using thin-layer chromatography. J Bacteriol 1975, 124:1566-1573.
168. Keleti G, Sykora JL, Lippy EC, Shapiro MA: Composition and biological properties of lipopolysaccharides isolated from Schizothrix calcicola (Ag.) Gomont (cyanobacteria). Appl Environ Microbiol 1979, 38:471-477.
169. Keleti G, Sykora JL: Production and properties of cyanobacterial endotoxins. Appl Environ Microbiol 1982, 43:104-109.
170. Movat HZ, Burrowes CE: The local Shwartzman reaction: endotoxin-mediated inflammatory and thrombo-hemorrhagic lesions. In Handbook of endotoxin Cellular biology of endotoxin Volume 3. Edited by: Berry LJ. Amsterdam: Elsevier Science Publishers; 1985:260-302.
171. Galdiero F, Sommese L, Scarfogliero P, Galdiero M: Biological activities - lethality, Shwartzman reaction and pyrogenicity - of Salmonella typhimurium porins. Microb Pathog 1994, 16:111-119.
172. Weise G, Drews G, Jann B, Jann K: Identification and analysis of a lipopolysaccharide in cell walls of the blue-green alga Anacystis nidulans. Arch Mikrobiol 1970, 71:89-98.
173. Schmidt W, Drews G, Weckesser J, Fromme I, Borowiak D: Characterization of the lipopolysaccharides from eight strains of the cyanobacterium Synechococcus. Arch Microbiol 1980, 127:209-215.
174. Best JH, Pflugmacher S, Wiegand C, Eddy FB, Metcalf JS, Codd GA: Effects of enteric bacterial and cyanobacterial lipopolysaccharides, and of microcystin-LR, on glutathione S-transferase activities in zebra fish (Danio rerio). Aquat Toxicol 2002, 60:223-231.
175. Kretzschmar M, Klinger W: The hepatic glutathione system - influences of xenobiotics. Exp Pathol 1990, 38:145-164.
176. Hentze H, Latta M, Künstle G, Lucas R, Wendel A: Redox control of hepatic cell death. Toxicol Lett 2003, 139:111-118.
177. Uhlig S, Wendel A: The physiological consequences of glutathione variations. Life Sci 1992, 51:1083-1094.
178. Dröge W, Schulze-Osthoff K, Mihm S, Galter D, Schenk H, Eck HP, Roth S, Gmünder H: Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 1994, 8:1131-1138.
179. van den Dobbelsteen DJ, Nobel CSI, Schlegel J, Cotgreave IA, Orrenius S, Slater AFG: Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J Biol Chem 1996, 271:15420-15427.
180. Hall AG: The role of glutathione in the regulation of apoptosis. Eur J Clin Invest 1999, 29:238-245.
181. Hentze H, Künstle G, Volbracht C, Ertel W, Wendel A: CD95-mediated murine hepatic apoptosis requires an intact glutathione status. Hepatology 1999, 30:177-185.
182. Hehner SP, Breitkreutz R, Shubinsky G, Unsoeld H, Schulze-Osthoff K, Schmitz ML, Dröge W: Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J Immunol 2000, 165:4319-4328.
183. Hentze H, Schmitz I, Latta M, Krueger A, Krammer PH, Wendel A: Glutathione dependence of caspase-8 activation at the death-inducing signaling complex. J Biol Chem 2002, 277:5588-5595.
184. Musallam L, Éthier C, Haddad PS, Denizeau F, Bilodeau M: Resistance to Fas-induced apoptosis in hepatocytes: role of GSH depletion by cell isolation and culture. Am J Physiol Gastrointest Liver Physiol 2002, 283:G709-718.
185. Tiegs G, Wendel A: Leukotriene-mediated liver injury. Biochem Pharmacol 1988, 37:2569-2573.
186. Jones JJ, Fan J, Nathens AB, Kapus A, Shekhman M, Marshall JC, Parodo J, Rotstein OD: Redox manipulation using the thiol-oxidizing agent diethyl maleate prevents hepatocellular necrosis and apoptosis in a rodent endotoxemia model. Hepatology 1999, 30:714-724.
187. Hentze H, Gantner F, Kolb SA, Wendel A: Depletion of hepatic glutathione prevents death receptor-dependent apoptotic and necrotic liver injury in mice. Am J Pathol 2000, 156:2045-2056.
188. Nathens AB, Marshall JC, Watson RWG, Dackiw APB, Rotstein OD: Diethylmaleate attenuates endotoxin-induced lung injury. Surgery 1996, 120:360-366.
189. Nathens AB, Bitar R, Watson RWG, Issekutz TB, Marshall JC, Dackiw APB, Rotstein OD: Thiol-mediated regulation of ICAM-1 expression in endotoxin-induced acute lung injury. J Immunol 1998, 160:2959-2966.
190. Szászi K, Jones JJ, Nathens AB, Lo AY, Marsden PA, Kapus A, Rotstein OD: Glutathione depletion inhibits lipopolysaccharide-induced intercellular adhesion molecule 1 synthesis. Free Radic Biol Med 2005, 38:1333-1343.
191. Chasseaud LF: The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res 1979, 29:175-274.
192. Langouët S, Mahéo K, Berthou F, Morel F, Lagadic-Gossman D, Glaise D, Coles B, Ketterer B, Guillouzo A: Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture. Carcinogenesis 1997, 18:1343-1349.
193. Mahéo K, Morel F, Antras-Ferry J, Langouët S, Desmots F, Corcos L, Guillouzo A: Endotoxin suppresses the oltipraz-mediated induction of major hepatic glutathione transferases and cytochromes P450 in the rat. Hepatology 1998, 28:1655-1662.
194. Schnayer N, Jenifer FG: Inactivation of blue-green alga virus, AS-1, by isolated host lipopolysaccharide. Proc Am Phytopathol Soc 1974, 1:144.
195. Samimi B, Drews G: Adsorption of cyanophage AS-1 to unicellular cyanobacteria and isolation of receptor material from Anacystis nidulans. J Virol 1978, 25:164-174.
196. Jones JH, Yopp JH: Cell wall constituents of Aphanothece halophytica (cyanophyta). J Phycol 1979, 15:62-66.
197. Schmidt W, Drews G, Weckesser J, Mayer H: Lipopolysaccharides in four strains of the unicellular cyanobacterium Synechocystis. Arch Microbiol 1980, 127:217-222.
198. Martin C, Codd GA, Siegelman HW, Weckesser J: Lipopolysaccharides and polysaccharides of the cell envelope of toxic Microcystis aeruginosa strains. Arch Microbiol 1989, 152:90-94.
199. Schneider S, Jürgens UJ: Cell wall and sheath constituents of the cyanobacterium Gloeobacter violaceus. Arch Microbiol 1991, 156:312-318.
200. Xu X, Khudyakov I, Wolk CP: Lipopolysaccharide dependence of cyanophage sensitivity and aerobic nitrogen fixation in Anabaena sp. strain PCC 7120. J Bacteriol 1997, 179:2884-2891.
201. Mayer H, Weckesser J: 'Unusual' lipid A's: structures, taxonomical relevance and potential value for endotoxin research. In Handbook of endotoxin - Chemistry of endotoxin Volume 1. Edited by: Rietschel ET. Amsterdam: Elsevier; 1984:221-247.
202. Mikami T, Nagase T, Matsumoto T, Suzuki S, Suzuki M: Gelation of Limulus amoebocyte lysate by simple polysaccharides. Microbiol Immunol 1982, 26:403-409.
203. Roslansky PF, Novitsky TJ: Sensitivity of Limulus amebocyte lysate (LAL) to LAL-reactive glucans. J Clin Microbiol 1991, 29:2477-2483.
204. Tanamoto K: Dissociation of endotoxic activities in a chemically synthesized lipid A precursor after acetylation. Infect Immun 1995, 63:690-692.
205. Seydel U, Hawkins L, Schromm AB, Heine H, Scheel O, Koch MHJ, Brandenburg K: The generalized endotoxic principle. Eur J Immunol 2003, 33:1586-1592.
206. Rapala J, Lahti K, Rasanen LA, Esala AL, Niemela SI, Sivonen K: Endotoxins associated with cyanobacteria and their removal during drinking water treatment. Water Res 2002, 36:2627-2635.
207. Abdulqader G, Barsanti L, Tredici MR: Harvest of Arthrospira platensis from Lake Kossorom (Chad) and its household use among the Kanembu. J Appl Phycol 2000, 12:493-498.
208. Komárek J, Komárková J, Kling H: Filamentous cyanobacteria. In Freshwater algae of North America: ecology and classification Edited by: Wehr JD, Sheath RG. Massachusetts: Academic Press; 2003:117-196.
209. Ciferri O: Spirulina, the edible microorganism. Microbiol Rev 1983, 47:551-578.
210. Belay A, Ota Y, Miyakawa K, Shimamatsu H: Current knowledge on potential health benefits of Spirulina. J Appl Phycol 1993, 5:235-241.
211. Hayashi O, Katoh T, Okuwaki Y: Enhancement of antibody production in mice by dietary Spirulina platensis. J Nutr Sci Vitaminol (Tokyo) 1994, 40:431-441.
212. Qureshi MA, Garlich JD, Kidd MT: Dietary Spirulina platensis enhances humoral and cell-mediated immune functions in chickens. Immunopharmacol Immunotoxicol 1996, 18:465-476.
213. Salazar M, Martínez E, Madrigal E, Ruiz LE, Chamorro GA: Subchronic toxicity study in mice fed Spirulina maxima. J Ethnopharmacol 1998, 62:235-241.
214. Al-Batshan HA, Al-Mufarrej SI, Al-Homaidan AA, Qureshi MA: Enhancement of chicken macrophage phagocytic function and nitrite production by dietary Spirulina platensis. Immunopharmacol Immunotoxicol 2001, 23:281-289.
215. Iwasa M, Yamamoto M, Tanaka Y, Kaito M, Adachi Y: Spirulina-associated hepatotoxicity. Am J Gastroenterol 2002, 97:3212-3213.
216. Matsumoto M, Einhaus D, Gold ES, Aderem A: Simvastatin Augments Lipopolysaccharide-Induced Proinflammatory Responses in Macrophages by Differential Regulation of the c-Fos and c-Jun Transcription Factors. J Immunol 2004, 172:7377-7384.
217. Gorham PR, Carmichael WW: Hazards of freshwater blue-green algae (cyanobacteria). In Algae and human affairs Edited by: Lembi CA, Waaland JR. Cambridge: Cambridge University Press; 1988:403-431.
218. Ballot A, Krienitz L, Kotut K, Wiegand C, Metcalf JS, Codd GA, Pflugmacher S: Cyanobacteria and cyanobacterial toxins in three alkaline Rift Valley lakes of Kenya - Lakes Bogoria, Nakuru and Elmenteita. J Plankton Res 2004, 26:925-935.
219. Ballot A, Krienitz L, Kotut K, Wiegand C, Pflugmacher S: Cyanobacteria and cyanobacterial toxins in the alkaline crater lakes Sonachi and Simbi, Kenya. Harmful Algae 2005, 4:139-150.
220. Codd GA, Metcalf JS, Morrison LF, Krienitz L, Ballot A, Pflugmacher S, Wiegand C, Kotut K: Susceptibility of flamingos to cyanobacterial toxins via feeding. Vet Rec 2003, 152:722-723.
221. Krienitz L, Ballot A, Kotut K, Wiegand C, Pütz S, Metcalf JS, Codd GA, Pflugmacher S: Contribution of hot spring cyanobacteria to the mysterious deaths of Lesser Flamingos at Lake Bogoria, Kenya. FEMS Microbiol Ecol 2003, 43:141-148.
222. Ndetei R, Muhandiki VS: Mortalities of lesser flamingos in Kenyan Rift Valley saline lakes and the implications for sustainable management of the lakes. Lakes Reserv Res Manage 2005, 10:51-58.
223. Tornabene TG, Bourne TF, Raziuddin S, Ben-Amotz A: Lipid and lipopolysaccharide constituents of cyanobacterium Spirulina platensis (Cyanophyceae, Nostocales). Mar Ecol Prog Ser 1985, 22:121-125.
224. Falconer IR: An overview of problems caused by toxic blue-green algae (cyanobacteria) in drinking and recreational water. Environ Toxicol 1999, 14:5-12.
225. Schaeffer DJ, Malpas PB, Barton LL: Risk assessment of microcystin in dietary Aphanizomenon flos-aquae. Ecotoxicol Environ Saf 1999, 44:73-80.
226. Gilroy DJ, Kauffman KW, Hall RA, Huang X, Chu FS: Assessing potential health risks from microcystin toxins in blue-green algae dietary supplements. Environ Health Perspect 2000, 108:435-439.
227. Saker ML, Jungblut AD, Neilan BA, Rawn DFK, Vasconcelos VM: Detection of microcystin synthetase genes in health food supplements containing the freshwater cyanobacterium Aphanizomenon flos-aquae. Toxicon 2005, 46:555-562.
228. Lawrence JF, Niedzwiadek B, Menard C, Lau BPY, Lewis D, Kuper-Goodman T, Carbone S, Holmes C: Comparison of liquid chromatography/mass spectrometry, ELISA, and phosphatase assay for the determination of microcystins in blue-green algae products. J AOAC Int 2001, 84:1035-1044.
229. Brüll LP, Huang Z, Thomas-Oates JE, Paulsen BS, Cohen EH, Michaelsen TE: Studies of polysaccharides from three edible species of Nostoc (cyanobacteria) with different colony morphologies: Structural characterization and effect on the complement system of polysaccharides from Nostoc commune. J Phycol 2000, 36:871-881.
230. Olenchock SA: Airborne endotoxin. In Manual of environmental microbiology Edited by: Hurst CJ, Knudsen GR, McInerney MJ, Stetzenbach LD, Walter MV. Washington: ASM Press; 1997:661-665.
231. Stetzenbach LD: Introduction to aerobiology. In Manual of environmental microbiology Edited by: Hurst CJ, Knudsen GR, McInerney MJ, Stetzenbach LD, Walter MV. Washington: ASM Press; 1997:619-628.
232. Michel O: Systemic and local airways inflammatory response to endotoxin. Toxicology 2000, 152:25-30.
233. Schwartz DA: Does inhalation of endotoxin cause asthma? Am J Respir Crit Care Med 2001, 163:305-306.
234. Rose CS, Martyny JW, Newman LS, Milton DK, King TE Jr, Beebe JL, McCammon JB, Hoffman RE, Kreiss K: "Lifeguard lung": endemic granulomatous pneumonitis in an indoor swimming pool. Am J Public Health 1998, 88:1795-1800.
235. Hunt LW, Gleich GJ, Ohnishi T, Weiler DA, Mansfield ES, Kita H, Sur S: Endotoxin contamination causes neutrophilia following pulmonary allergen challenge. Am J Respir Crit Care Med 1994, 149:1471-1475.
236. Kline JN, Cowden JD, Hunninghake GW, Schutte BC, Watt JL, Wohlford-Lenane CL, Powers LS, Jones MP, Schwartz DA: Variable airway responsiveness to inhaled lipopolysaccharide. Am J Respir Crit Care Med 1999, 160:297-303.
237. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000, 25:187-191.
238. Herz U, Lacy P, Renz H, Erb K: The influence of infections on the development and severity of allergic disorders. Curr Opin Immunol 2000, 12:632-640.
239. Riedler J, Eder W, Oberfeld G, Schreuer M: Austrian children living on a farm have less hay fever, asthma and allergic sensitization. Clin Exp Allergy 2000, 30:194-200.
240. Riedler J, Braun-Fahrlander C, Eder W, Schreuer M, Waser M, Maisch S, Carr D, Schierl R, Nowak D, von Mutius E: Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001, 358:1129-1133.
241. Reed CE, Milton DK: Endotoxin-stimulated innate immunity: A contributing factor for asthma. J Allergy Clin Immunol 2001, 108:157-166.
242. Douwes J, Pearce N, Heederik D: Does environmental endotoxin exposure prevent asthma? Thorax 2002, 57:86-90.
243. Yazdanbakhsh M, Kremsner PG, van Ree R: Allergy, parasites, and the hygiene hypothesis. Science 2002, 296:490-494.
244. Douwes J, Le Gros G, Gibson P, Pearce N: Can bacterial endotoxin exposure reverse atopy and atopic disease? J Allergy Clin Immunol 2004, 114:1051-1054.
245. Eldridge MW, Peden DB: Airway response to concomitant exposure with endotoxin and allergen in atopic asthmatics. J Toxicol Environ Health A 2000, 61:27-37.
246. Creasia DA: Acute inhalation toxicity of microcystin-LR with mice. Toxicon 1990, 28:605.
247. Fitzgeorge RB, Clark SA, Keevil CW: Routes of intoxication. In Detection methods for cyanobacterial toxins Edited by: Codd GA, Jefferies TM, Keevil CW, Potter E. Cambridge: The Royal Society of Chemistry; 1994:69-74.
248. Ito E, Kondo F, Harada K: Intratracheal administration of microcystin-LR, and its distribution. Toxicon 2001, 39:265-271.
249. Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, Summer WR: Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis 1989, 159:189-194.
250. Ghofrani HA, Rosseau S, Walmrath D, Kaddus W, Kramer A, Grimminger F, Lohmeyer J, Seeger W: Compartmentalized lung cytokine release in response to intravascular and alveolar endotoxin challenge. Am J Physiol 1996, 270:L62-68.
251. Stewart I, Webb PM, Schluter PJ, Shaw GR: Recreational and occupational field exposure to freshwater cyanobacteria - a review of anecdotal and case reports, epidemiological studies and the challenges for epidemiologic assessment. Environ Health 2006, 5(1):6. Mar 24
252. Poynter ME, Irvin CG, Janssen-Heininger YM: A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation. J Immunol 2003, 170:6257-6265.
253. Okamoto T, Gohil K, Finkelstein EI, Bove P, Akaike T, van der Vliet A: Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2004, 286:L198-209.
254. Spond J, Billah MM, Chapman RW, Egan RW, Hey JA, House A, Kreutner W, Minnicozzi M: The role of neutrophils in LPS-induced changes in pulmonary function in conscious rats. Pulm Pharmacol Ther 2004, 17:133-140.
255. Urbanik-Sypniewska T, Seydel U, Greck M, Weckesser J, Mayer H: Chemical studies on the lipopolysaccharide of Rhizobium meliloti 10406 and its lipid A region. Arch Microbiol 1989, 152:527-532.
256. Urbanik-Sypniewska T, Choma A, Kutkowska J, Kaminska T, Kandefer-Szerszen M, Russa R, Dolecka J: Cytokine inducing activities of rhizobial and mesorhizobial lipopolysaccharides of different lethal toxicity. Immunobiology 2000, 202:408-420.
257. Pilotto L, Hobson P, Burch MD, Ranmuthugala G, Attewell R, Weightman W: Acute skin irritant effects of cyanobacteria (blue-green algae) in healthy volunteers. Aust N Z J Public Health 2004, 28:220-224.
258. Stewart I, Robertson IM, Webb PM, Schluter PJ, Shaw GR: Cutaneous hypersensitivity reactions to freshwater cyanobacteria - human volunteer studies. BMC Dermatol 2006, 6:6.
259. Stewart I, Seawright AA, Schluter PJ, Shaw GR: Primary irritant and delayed-contact hypersensitivity reactions to the freshwater cyanobacterium Cylindrospermopsis raciborskii and its associated toxin cylindrospermopsin. BMC Dermatol 2006, 6:5.
260. Bennett IL Jr: Approaches to the mechanisms of endotoxin action. In Bacterial endotoxins Edited by: Landy M, Braun W. New Brunswick: Institute of Microbiology, Rutgers, The State University of New Jersey; 1964:xiii-xvi.
261. Ressom R, Soong FS, Fitzgerald J, Turczynowicz L, El Saadi O, Roder D, Maynard T, Falconer I: Health effects of toxic cyanobacteria (blue-green algae). Canberra: National Health and Medical Research Council & Australian Government Publishing Service; 1994.
262. Sykora JL, Keleti G, Roche R, Volk DR, Kay GP, Burgess RA, Shapiro MA, Lippy EC: Endotoxins, algae and Limulus amoebocyte lysate test in drinking water. Water Res 1980, 14:829-839.
263. Gerba CP, Goyal SM: Potential for groundwater contamination by algal endotoxins. In The water environment - Algal toxins and health Edited by: Carmichael WW. New York: Plenum; 1981:303-314.
264. Beasley VR, Cook WO, Dahlem AM, Hooser SB, Lovell RA, Valentine WM: Algae intoxication in livestock and waterfowl. Vet Clin North Am Food Anim Pract 1989, 5:345-361.
265. Bagchi SN: Cyanobacterial toxins. J Sci Ind Res (India) 1996, 55:715-727.
266. Tyagi MB, Thakur JK, Singh DP, Kumar A, Prasuna EG, Kumar A: Cyanobacterial toxins: the current status. J Microbiol Biotechnol 1999, 9:9-21.
267. Mankiewicz J, Tarczynska M, Walter Z, Zalewski M: Natural toxins from cyanobacteria. Acta Biol Cracov Ser Bot 2003, 45:9-20.
268. Codd GA, Morrison LF, Metcalf JS: Cyanobacterial toxins: risk management for health protection. Toxicol Appl Pharmacol 2005, 203:264-272.
269. National Rivers Authority (NRA): Toxic blue-green algae. Water Quality Series No. 2. London: National Rivers Authority; 1990.
270. Drikas M: Control and/or removal of algal toxins. In Toxic cyanobacteria: current status of research and management Edited by: Steffensen DA, Nicholson BC. Salisbury: Australian Centre for Water Quality Research; 1994:93-101.
271. Yoo RS, Carmichael WW, Hoehn RC, Hrudey SE: Cyanobacterial (blue-green algal) toxins: A resource guide. Denver: AWWA Research Foundation and American Water Works Association; 1995.
272. Codd GA, Ward CJ, Bell SG: Cyanobacterial toxins: occurrence, modes of action, health effects and exposure routes. Arch Toxicol Suppl 1997, 19:399-410.
273. Pitois S, Jackson MH, Wood BJB: Problems associated with the presence of cyanobacteria in recreational and drinking water. Int J Environ Health Res 2000, 10:203-218.
274. Queensland Water Quality Task Force: Freshwater algal blooms in Queensland. Brisbane: Queensland Water Quality Task Force; 1992.
275. Leder K, Sinclair MI, McNeil JJ: Water and the environment: a natural resource or a limited luxury? Med J Aust 2002, 177:609-613.
276. Drinking water facts - Blue green algae: a guide [http://www. waterquality.crc.org.au/DWFacts/DWFact_Algae.pdf]
277. Chorus I: Algal metabolites and water quality: Toxins, allergens, and taste-and-odor problems. Mem Ist Ital Idrobiol 1993, 52:570-572.
278. Johnstone P: Guidelines for the recreational use of water potentially containing cyanobacteria. Occasional paper SWR No. 1. Canberra: Sub-committee on Water Resources, Sustainable Land and Water Resources Management Committee, Agriculture and Resource Management Council of Australia and New Zealand; 1995.
279. Marshall I, Smith M, Neville G: Health risk assessment and management of a cyanobacterial bloom affecting a non-municipal water supply. Environ Health 2001, 1:94-102.
280. Falconer IR: Health implications of cyanobacterial (blue-green algal) toxins. In Toxic cyanobacteria: current status of research and management Edited by: Steffensen DA, Nicholson BC. Salisbury: Australian Centre for Water Quality Research; 1994:61-65.
281. Falconer IR: Toxic cyanobacterial bloom problems in Australian waters: risks and impacts on human health. Phycologia 2001, 40:228-233.
282. Codd GA, Bell SG, Brooks WP: Cyanobacterial toxins in water. Water Sci Technol 1989, 21:1-13.
283. Fitzgerald DJ: Cyanotoxins and human health - overview. In Cyanotoxins - occurrence, causes, consequences Edited by: Chorus I. Berlin: Springer-Verlag; 2001:179-190.
284. A malaria-like syndrome after baths and showers in cyanobacteria- contaminated water: the importance of lipopoly saccharide endotoxins [http://www.inweh.unu.edu/lvfo/lv2000%20abstracts.htm]
285. Blue-green algal bloom management: NSW Murray Regional Algal Coordinating Committee [http://www.murraybluegreenalgae.com/detailed_biology.htm]
286. Mikheyskaya LV, Ovodova RG, Ovodov YS: Isolation and characterization of lipopolysaccharides from cell walls of blue-green algae of the genus Phormidium. J Bacteriol 1977, 130:1-3.